Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.
Article in American Journal of Respiratory Cell and Molecular Biology (September 2022)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in American Journal of Respiratory Cell and Molecular Biology (September 2022)
Article in JCI Insight (May 2022)
Article in Nutrition in Clinical Practice (March 2022)